Table 1.
Analysis 1 | ||
Group 1 | No. of ASOR-positive vesicles | 301 |
Group 2 | No. in group 1 positive for Kifc1 | 176 |
Group 3 | No. in group 2 positive for Kif5B | 162 |
% of Kifc1 vesicles with Kif5B | 92% | |
% of ASOR vesicles with KifC1 and Kif5B | 54% | |
Analysis 2 | ||
Group 4 | No. of ASOR-positive vesicles | 309 |
Group 5 | No. in group 4 positive for Kif5B | 235 |
Group 6 | No. in group 5 positive for Kifc1 | 161 |
% of Kif5B vesicles with Kifc1 | 69% | |
% of ASOR vesicles with KifC1 and Kif5B | 52% |
Texas Red ASOR-containing early endocytic vesicles from wild-type mouse liver were bound to an optical chamber and immunostained for Kifc1 and Kif5B sequentially as described in Materials and Methods. In the first image analysis (analysis 1), ASOR-containing vesicles were identified (group 1), and those that also contained Kifc1 (group 2) were quantified. Next, the fraction of the group 2 vesicles that also contained Kif5B was quantified. Image analysis of ASOR-containing vesicles was also done in the reverse order (analysis 2).